About Bluesight
Bluesight is a Healthcare company based in Alexandria (United States) founded in 2011 by Tim Kress-Spatz and Kevin Macdonald. AI-based platform for medication data and analytics in pharmacies. Bluesight has raised $10.5 million across 2 funding rounds from investors including New Leaf Venture Partners, Thoma Bravo and Easton Capital Investment Group. The company has 115 employees. Bluesight has completed 3 acquisitions, including Medacist, Protenus and Sectyr. Its chief executive, as recorded, is Kevin Macdonald. Its website bluesight.com draws about 26 thousand monthly visits. Bluesight offers products and services including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring. Its focus areas include HealthTech, Pharmacy IT and Drug Diversion Analytics. Its competitors include HelioMetrics and DocRX.
Company details
AI-based medication data and analytics platform for pharmacies. It offers pharmaceutical intelligence and provides hospital pharmacies solutions for managing drug diversion, RFID medication monitoring, and pharmacy purchasing. They provide cloud-based software that uses data from electronic medical records and automated dispensing cabinets to proactively detect drug diversion. Additionally, they offer a practice guide for drug diversion programs and use analytics to improve drug spending and workflows.
- Headquarters Alexandria, United States
- Employees 115
- Founders Tim Kress-Spatz, Kevin Macdonald
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bluesight.com
- Social LinkedIn X Facebook
- Total Equity Funding$10.5M (USD)
in 2 rounds
- InvestorsNew Leaf Venture Partners
& 4 more
- Employee Count115
- Investments & AcquisitionsMedacist
& 2 more
Products & Services of Bluesight
Bluesight offers a comprehensive portfolio of products and services, including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Automates restocking and tracking of medications in hospitals
Monitors and prevents drug diversion in healthcare settings
Modernizes retail purchasing for pharmacy operations
Optimizes drug purchasing and handles shortages compliance
Detects and manages privacy violations in healthcare data
Funding Insights of Bluesight
Bluesight has successfully raised a total of $10.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.5M
- Total Rounds 2
- First Round $10.5M
(Jul 2013)
- Investors Count 5
All 2 funding rounds of Bluesight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2023 | Private Equity Round | – | Thoma Bravo | ||
| Jul 2013 | $10.5M | Series A | – | New Leaf Venture Partners |
5 investors in total: 5 institutional.
Investors in Bluesight
Bluesight has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include New Leaf Venture Partners, Thoma Bravo and Easton Capital Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Software and technology-enabled services companies are targeted for investment. | 1980 | thomabravo.com | Chicago, United States | |
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
| eastoncapital.com | ||||
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Early-stage healthcare investments are managed by LionBird venture capital firm. | lionbird.com | Tel Aviv, Israel |
Investor details for Bluesight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bluesight
2 people are tracked at Bluesight (2 in leadership); the tracked headcount is 115.
| Name | Role | Group |
|---|---|---|
Tim Kress-Spatz | Co-Founder | Leadership |
Kevin Macdonald | Co-Founder & CEO | Leadership |
Complete people profiles for Bluesight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bluesight
Bluesight has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Medacist, Protenus and Sectyr.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
AI-based insider threat detection and prevention solutions for healthcare sector | protenus.com | Baltimore, United States | 2014 | Jan 2025 | •••• | |
Cloud-based compliance solutions are provided for healthcare regulatory needs. | sectyr.com | Scottsdale, United States | 2017 | Oct 2024 | •••• | |
Provider of drug diversion and dosage solutions for healthcare industry | medacist.com | Cheshire, United States | 1998 | Jul 2023 | •••• |
Complete acquisition details for Bluesight
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bluesight
6 dated milestones of Bluesight across 14 years, from founding to its latest funding, stage changes and deals.
Competitors of Bluesight
Bluesight has 2 listed competitors in our database. They include HelioMetrics and DocRX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heliometrics.net | 2013 | Minneapolis, United States | Offers software to detect and analyze drug diversions in healthcare settings. | |||
| docrx.com | 2008 | Mobile, United States | Offers physician dispensing, medical supplies, and compliance services for healthcare. |
Detailed competitors of Bluesight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bluesight
The website of Bluesight (bluesight.com) receives about 25.8K visits a month.
- Monthly visits25.8K
▲ 18.7% vs previous month
Websites whose visitors overlap most with Bluesight. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| klasresearch.com | 100% | 41.2K | #764,221 | View details | |
| google.com | 34% | 85.8B | #1 | View details |
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as Bluesight (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bluesight
Complete news archive for Bluesight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bluesight
Bluesight was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Bluesight is headquartered in Alexandria, United States.
Kevin Macdonald is the CEO of Bluesight, as recorded in our data. They have also founded this company.
Bluesight is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10.5M, raised on Jul 2013.
Bluesight has 115 employees.
AI-based medication data and analytics platform for pharmacies. It offers pharmaceutical intelligence and provides hospital pharmacies solutions for managing drug diversion, RFID medication monitoring, and pharmacy purchasing. They provide cloud-based software that uses data from electronic medical records and automated dispensing cabinets to proactively detect drug diversion. Additionally, they offer a practice guide for drug diversion programs and use analytics to improve drug spending and workflows.
Bluesight's top competitors include HelioMetrics and DocRX.
Bluesight offers RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Bluesight has 5 investors. Key investors include New Leaf Venture Partners, Thoma Bravo, Easton Capital Investment Group, Sands Capital Ventures, and LionBird.